QUESTRAN Side Effects

6836460-6 | Diastematomyelia
on Jul 05, 2010 Female patient from FRANCE , weighting 6.61 lb, was treated with Questran (View Usage). Patient experienced the following unwanted or unexpected effects: diastematomyelia. Questran dosage: Questran Powder 4 G Half A Sachet A Day Orally By Mother. During the same period patient was treated with IMUREL (125 Milligram/d Then 50 Mg/d In The Third Trimester) (View Imurel Review and Imurel Label ), VITAMIN B 12 (1000/gamma/month.) (View Vitamin B-12 Review and Vitamin B-12 Label ).

6764364-6 | Anaemia Macrocytic, Eosinophilia, Iron Deficiency, Malnutrition, Nausea, Pruritus, Renal Failure
Patient was taking Questran (View Usage). Patient had the following side effects: anaemia macrocytic, eosinophilia, iron deficiency, malnutrition, nausea (What is nausea?), pruritus, renal failure on Jun 07, 2010 from FRANCE Additional patient health information: Male patient , 72 years of age, was diagnosed with embolism and. Questran dosage: . During the same period patient was treated with PREVISCAN (View Previscan Review and Previscan Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), KENZEN (16mg;1df=1 Scored Tablet) (View Kenzen Review and Kenzen Label ), TORENTAL (800mg Daily) (View Torental Review and Torental Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), KARDEGIC (View Kardegic Review and Kardegic Label ), NEXIUM (View Nexium Review and Nexium Label ), FORTIMEL (Food Complement) (View Fortimel Review and Fortimel Label ). Patient was hospitalized.

6736316-3 | Constipation, Rash Pruritic, Skin Swelling
Adverse event was reported on May 20, 2010 by a Female patient taking Questran (View Usage) (Dosage: 1 Scoop 2 X /day Mixed In Water) was diagnosed with blood cholesterol increased and. Location: UNITED STATES , 55 years of age, weighting 138.2 lb, After Questran was administered, patient had the following side effects: constipation (What is constipation?), rash pruritic, skin swelling.

6716249-9 | Adverse Event, Dehydration
on Apr 28, 2010 Female patient from UNITED KINGDOM , 72 years of age, was treated with Questran (View Usage). Patient experienced the following unwanted or unexpected effects: adverse event, dehydration. Questran dosage: 4df-4sachets. During the same period patient was treated with QUESTRAN LIGHT (View Questran Light Review and Questran Light Label ).


6658628-4 | Anaemia Macrocytic, Eosinophilia, Iron Deficiency, Malnutrition, Nausea, Pruritus, Renal Failure
on Mar 22, 2010 Male patient from FRANCE , 72 years of age, was diagnosed with embolism and was treated with Questran (View Usage). Patient had the following side effects: anaemia macrocytic, eosinophilia, iron deficiency, malnutrition, nausea (What is nausea?), pruritus, renal failure. Questran dosage: . During the same period patient was treated with PREVISCAN (View Previscan Review and Previscan Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), KENZEN (16mg;1df=1 Scored Tablet) (View Kenzen Review and Kenzen Label ), TORENTAL (800mg Daily) (View Torental Review and Torental Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), KARDEGIC (View Kardegic Review and Kardegic Label ), NEXIUM (View Nexium Review and Nexium Label ), FORTIMEL (Food Complement) (View Fortimel Review and Fortimel Label ). Patient was hospitalized.

6631636-5 | Blood Creatine Phosphokinase Increased
Patient was taking Questran (View Usage). After Questran was administered, patient had the following side effects: blood creatine phosphokinase increased on Mar 10, 2010 from FRANCE Additional patient health information: Male patient , 75 years of age, . Questran dosage: 1 Df=3 Sachets Intially,then 2 Sachets For More Than 1 Year. During the same period patient was treated with ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ), LERCAN (View Lercan Review and Lercan Label ).

6552138-0 | Muscle Atrophy, Muscle Spasms, Muscular Weakness, Myalgia
Adverse event was reported on Jan 09, 2010 by a Female patient taking Questran (View Usage) (Dosage: (1 Df Qd, One Scoop Per Day Oral)) was diagnosed with intestinal functional disorder and. Location: UNITED STATES , 75 years of age, Patient experienced the following unwanted or unexpected effects: muscle atrophy, muscle spasms, muscular weakness, myalgia. During the same period patient was treated with SYNTHROID (View Synthroid Review and Synthroid Label ).

6505295-6 | Migraine
on Apr 01, 2009 Female patient from UNITED STATES , 57 years of age, weighting 154.3 lb, was diagnosed with diarrhoea and was treated with Questran (View Usage). Patient had the following side effects: migraine (What is migraine?). Questran dosage: .

6475576-3 | Dehydration, Diarrhoea, Renal Failure Acute
on Dec 01, 2009 Male patient from UNITED STATES , 42 years of age, weighting 152.1 lb, was diagnosed with crohn's disease (What is crohn's disease?) and was treated with Questran (View Usage). After Questran was administered, patient had the following side effects: dehydration, diarrhoea, renal failure acute. Questran dosage: . During the same period patient was treated with REMICADE (Remicade Lyophilized Powder Received 8inf Also Received On 22aug03-stopped) (View Remicade Review and Remicade Label ), IMODIUM (View Imodium Review and Imodium Label ), NEXIUM (View Nexium Review and Nexium Label ), PEDIALYTE (View Pedialyte Review and Pedialyte Label ), XIFAXAN (View Xifaxan Review and Xifaxan Label ), CIMZIA (View Cimzia Review and Cimzia Label ). Patient was hospitalized.

6444374-9 | Decreased Appetite, Vomiting
Patient was taking Questran (View Usage). Patient experienced the following unwanted or unexpected effects: decreased appetite, vomiting on Nov 13, 2009 from BRAZIL Additional patient health information: Female patient , 28 years of age, . Questran dosage: . Patient was hospitalized.

6366563-4 | Dehydration, Renal Failure Acute
Adverse event was reported on Sep 17, 2009 by a Male patient taking Questran (View Usage) (Dosage: ) was diagnosed with crohn's disease (What is crohn's disease?) and. Location: UNITED STATES , 42 years of age, weighting 152.1 lb, Patient had the following side effects: dehydration, renal failure acute. During the same period patient was treated with REMICADE (Remicade Lyophilized Powder Received 8inf Also Received On 22aug03) (View Remicade Review and Remicade Label ), IMODIUM (View Imodium Review and Imodium Label ), NEXIUM (View Nexium Review and Nexium Label ), PEDIALYTE (View Pedialyte Review and Pedialyte Label ), XIFAXAN (View Xifaxan Review and Xifaxan Label ), CERTOLIZUMAB PEGOL (View Certolizumab Pegol Review and Certolizumab Pegol Label ). Patient was hospitalized.

6122570-8 | Spine Malformation
on Mar 16, 2009 Female patient from FRANCE , weighting 6.61 lb, was treated with Questran (View Usage). After Questran was administered, patient had the following side effects: spine malformation. Questran dosage: Questran Powder 4 G Half A Sachet A Day Orally By Mother. During the same period patient was treated with IMUREL (125 Milligram/d Then 50 Mg/d In The Third Trimester) (View Imurel Review and Imurel Label ), VITAMIN B 12 (1000/gamma/month.) (View Vitamin B-12 Review and Vitamin B-12 Label ).

6108822-6 | Arthralgia, Headache, Myalgia, Organising Pneumonia
on Mar 04, 2009 Female patient from FRANCE , 64 years of age, was diagnosed with hypercholesterolaemia, osteoporosis (What is osteoporosis?) and was treated with Questran (View Usage). Patient experienced the following unwanted or unexpected effects: arthralgia, headache (What is headache?), myalgia, organising pneumonia. Questran dosage: . During the same period patient was treated with CRESTOR (View Crestor Review and Crestor Label ), FRACTAL (View Fractal Review and Fractal Label ), LESCOL (View Lescol Review and Lescol Label ), ZOCOR (1df=1 Unit (units Not Specified)) (View Zocor Review and Zocor Label ), EZETROL (Form: Tablet) (View Ezetrol Review and Ezetrol Label ), LIPANTHYL (View Lipanthyl Review and Lipanthyl Label ), BONIVA (View Boniva Review and Boniva Label ). Patient was hospitalized.

6104732-9 | Dehydration, Unevaluable Event
Patient was taking Questran (View Usage). Patient had the following side effects: dehydration, unevaluable event on Feb 26, 2009 from UNITED STATES Additional patient health information: Male patient , weighting 231.0 lb, was diagnosed with crohn's disease (What is crohn's disease?) and. Questran dosage: Df. During the same period patient was treated with REMICADE (Df Intravenous (not Otherwise Specified), 5 Mg/kg Intravenous (not Otherwise Specified)), 5 Mg/kg In) (View Remicade Review and Remicade Label ), VITAMIN B12 /00056201/ (NOT SPECIFIED) (Df) (View Vitamin B12 /00056201/ (not Specified) Review and Vitamin B12 /00056201/ (not Specified) Label ), HUMIRA (Df) (View Humira Review and Humira Label ). Patient was hospitalized.

6101610-6 | Dehydration
Adverse event was reported on Feb 27, 2009 by a Male patient taking Questran (View Usage) (Dosage: ) was diagnosed with crohn's disease (What is crohn's disease?) and. Location: UNITED STATES , 57 years of age, weighting 231.5 lb, After Questran was administered, patient had the following side effects: dehydration. During the same period patient was treated with CYANOCOBALAMIN (View Cyanocobalamin Review and Cyanocobalamin Label ), REMICADE (View Remicade Review and Remicade Label ), HUMIRA (View Humira Review and Humira Label ). Patient was hospitalized.

6062641-8 | Organising Pneumonia
on Jan 28, 2009 Female patient from FRANCE , 64 years of age, was diagnosed with hypercholesterolaemia, osteoporosis (What is osteoporosis?) and was treated with Questran (View Usage). Patient experienced the following unwanted or unexpected effects: organising pneumonia. Questran dosage: . During the same period patient was treated with CRESTOR (View Crestor Review and Crestor Label ), FRACTAL (View Fractal Review and Fractal Label ), LESCOL (View Lescol Review and Lescol Label ), ZOCOR (1df=1 Unit (units Not Specified)) (View Zocor Review and Zocor Label ), EZETROL (Form: Tablet) (View Ezetrol Review and Ezetrol Label ), LIPANTHYL (View Lipanthyl Review and Lipanthyl Label ), BONIVA (View Boniva Review and Boniva Label ). Patient was hospitalized.

6001006-1 | Hypersensitivity
on Sep 22, 2008 Female patient from UNITED STATES , 57 years of age, was treated with Questran (View Usage). Patient had the following side effects: hypersensitivity. Questran dosage: . During the same period patient was treated with ATENOLOL (View Atenolol Review and Atenolol Label ).

6001004-8 | Malaise, Nausea
Patient was taking Questran (View Usage). After Questran was administered, patient had the following side effects: malaise, nausea (What is nausea?) on Jul 23, 2008 from UNITED STATES Additional patient health information: Female patient , 39 years of age, was diagnosed with diarrhoea and. Questran dosage: Switched To Cholestyramine Of Ndc 49884-791-65 Which She Received Initially.

6000997-2 | Dyspepsia, Flatulence
Adverse event was reported on Feb 07, 2008 by a Male patient taking Questran (View Usage) (Dosage: 2 Dosage Form = 2 Teaspoon, Strength Is 378 G.) was diagnosed with diarrhoea and. Location: UNITED STATES , 66 years of age, weighting 205.0 lb, Patient experienced the following unwanted or unexpected effects: dyspepsia, flatulence. During the same period patient was treated with GLUCOPHAGE (View Glucophage Review and Glucophage Label ).

5999295-2 | Metabolic Acidosis, Renal Failure
on Dec 10, 2008 Male patient from FRANCE , 85 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?), hypertension, depression (What is depression?), osteoporosis (What is osteoporosis?), benign prostatic hyperplasia, neuralgia and was treated with Questran (View Usage). Patient had the following side effects: metabolic acidosis, renal failure. Questran dosage: . During the same period patient was treated with ARAVA (1 Tab) (View Arava Review and Arava Label ), CORTANCYL (View Cortancyl Review and Cortancyl Label ), TENORMIN (1 Tab) (View Tenormin Review and Tenormin Label ), STABLON (View Stablon Review and Stablon Label ), NEXIUM (1 Tab) (View Nexium Review and Nexium Label ), CACIT D3 (View Cacit D3 Review and Cacit D3 Label ), XATRAL LP (1 Tab) (View Xatral Lp Review and Xatral Lp Label ), LYRICA (2 Capsules) (View Lyrica Review and Lyrica Label ). Patient was hospitalized.

5842789-0 | Abdominal Pain, Dehydration, Diarrhoea, Electrolyte Imbalance, Gastrointestinal Stoma Complication, Infusion Related Reaction, Nausea, Rash
on Aug 04, 2008 Male patient from UNITED STATES , weighting 231.0 lb, was diagnosed with crohn's disease (What is crohn's disease?) and was treated with Questran (View Usage). After Questran was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), dehydration, diarrhoea, electrolyte imbalance, gastrointestinal stoma complication, infusion related reaction, nausea (What is nausea?), rash (What is rash?). Questran dosage: Df. During the same period patient was treated with REMICADE (See Image) (View Remicade Review and Remicade Label ), BUDESONIDE (Df) (View Budesonide Review and Budesonide Label ), IMODIUM (Df) (View Imodium Review and Imodium Label ), PREVACID (Df) (View Prevacid Review and Prevacid Label ), ADALIMUMAB (Df) (View Adalimumab Review and Adalimumab Label ). Patient was hospitalized.

5838764-2 | Abdominal Pain, Dehydration, Diarrhoea, Electrolyte Imbalance, Infusion Related Reaction, Post Procedural Discharge, Rash
Patient was taking Questran (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), dehydration, diarrhoea, electrolyte imbalance, infusion related reaction, post procedural discharge, rash (What is rash?) on Aug 05, 2008 from UNITED STATES Additional patient health information: Male patient , 56 years of age, weighting 231.5 lb, was diagnosed with crohn's disease (What is crohn's disease?) and. Questran dosage: . During the same period patient was treated with REMICADE (16nov1999-unk + 18jan2001-unk: 5mg/kg 06aug2001:10mg/kg Lyophilized Powder(recombinant)) (View Remicade Review and Remicade Label ), BUDESONIDE (View Budesonide Review and Budesonide Label ), IMODIUM (View Imodium Review and Imodium Label ), PREVACID (View Prevacid Review and Prevacid Label ), ADALIMUMAB (View Adalimumab Review and Adalimumab Label ), LOMOTIL (View Lomotil Review and Lomotil Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ). Patient was hospitalized.

5525629-9 | Abdominal Distension, Activated Partial Thromboplastin Time Prolonged, Blood Potassium Decreased, Blood Sodium Decreased, Cardiac Arrest, Heart Rate Increased, International Normalised Ratio Increased, Pco2 Decreased, Sepsis
Adverse event was reported on Nov 21, 2007 by a Male patient taking Questran (View Usage) (Dosage: ) was diagnosed with diarrhoea and. Location: BRAZIL , child 2 years of age, weighting 26.46 lb, Patient had the following side effects: abdominal distension, activated partial thromboplastin time prolonged, blood potassium decreased, blood sodium decreased, cardiac arrest (What is cardiac arrest?), heart rate increased, international normalised ratio increased, pco2 decreased, sepsis (What is sepsis?). Patient was hospitalized.

5519974-0 | Constipation
on Sep 19, 2007 Female patient from UNITED STATES , 63 years of age, weighting 149.9 lb, was treated with Questran (View Usage). After Questran was administered, patient had the following side effects: constipation (What is constipation?). Questran dosage: 1 Packet Daily Till 20 Years Ago To 16-sep-2007 And 1 Pack Every Other Day From 17-sep-2007 Onwards.. During the same period patient was treated with VITAMIN K (View Vitamin K Review and Vitamin K Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), FOSAMAX (View Fosamax Review and Fosamax Label ), NEXIUM (View Nexium Review and Nexium Label ).

5519972-7 | Diarrhoea, Weight Gain Poor
on May 15, 2007 Female patient from UNITED STATES , 61 years of age, was diagnosed with diarrhoea and was treated with Questran (View Usage). Patient experienced the following unwanted or unexpected effects: diarrhoea, weight gain poor. Questran dosage: . During the same period patient was treated with PREVALITE (View Prevalite Review and Prevalite Label ).

5519968-5 | Blood Phosphorus Increased
Patient was taking Questran (View Usage). Patient had the following side effects: blood phosphorus increased on Jan 11, 2007 from UNITED STATES Additional patient health information: Female patient , 60 years of age, was diagnosed with blood triglycerides increased and. Questran dosage: Dosage Form = Packet. During the same period patient was treated with PHOSLO (View Phoslo Review and Phoslo Label ), TUMS (View Tums Review and Tums Label ).

5519967-3 | Nausea
Adverse event was reported on Dec 26, 2006 by a Male patient taking Questran (View Usage) (Dosage: ) . Location: UNITED STATES , weighting 138.9 lb, After Questran was administered, patient had the following side effects: nausea (What is nausea?). During the same period patient was treated with GLYBURIDE (View Glyburide Review and Glyburide Label ), DIOVAN (View Diovan Review and Diovan Label ).

5519966-1 | Dysgeusia
on Dec 20, 2006 Female patient from UNITED STATES , 28 years of age, was diagnosed with increased appetite and was treated with Questran (View Usage). Patient experienced the following unwanted or unexpected effects: dysgeusia. Questran dosage: Patient Had Been On Questran 2x/day Since Nov 2005; Complained In Dec 2006 Of Taste.

5316625-5 | Fistula, Infection, Intestinal Stenosis
on May 03, 2007 Female patient from UNITED STATES , 65 years of age, weighting 130.1 lb, was diagnosed with crohn's disease (What is crohn's disease?) and was treated with Questran (View Usage). Patient had the following side effects: fistula (What is fistula?), infection (What is infection?), intestinal stenosis. Questran dosage: . Patient was hospitalized.

5308292-1 | Blood Potassium Increased, Blood Sodium Decreased, Dehydration, Weight Decreased
Patient was taking Questran (View Usage). After Questran was administered, patient had the following side effects: blood potassium increased, blood sodium decreased, dehydration, weight decreased on Apr 23, 2007 from UNITED STATES Additional patient health information: Male patient , weighting 9.00 lb, was diagnosed with diarrhoea and. Questran dosage: 500mg 2 Times Daily Po. Patient was hospitalized.

5305984-5 | Neutropenia
Adverse event was reported on Jan 25, 2007 by a Male patient taking Questran (View Usage) (Dosage: ) was diagnosed with overdose, cardiac operation and. Location: FRANCE , 70 years of age, Patient experienced the following unwanted or unexpected effects: neutropenia. During the same period patient was treated with PYOSTACINE (View Pyostacine Review and Pyostacine Label ), TAHOR (View Tahor Review and Tahor Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), PREVISCAN (View Previscan Review and Previscan Label ), CORDARONE (View Cordarone Review and Cordarone Label ), IRBESARTAN (View Irbesartan Review and Irbesartan Label ), LASIX (View Lasix Review and Lasix Label ), GLUCOPHAGE (View Glucophage Review and Glucophage Label ). Patient was hospitalized.

5222367-7 | Neutropenia
on Jan 25, 2007 Male patient from FRANCE , 70 years of age, was diagnosed with overdose, cardiac operation and was treated with Questran (View Usage). Patient had the following side effects: neutropenia. Questran dosage: . During the same period patient was treated with PYOSTACINE (View Pyostacine Review and Pyostacine Label ), TAHOR (View Tahor Review and Tahor Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), PREVISCAN (View Previscan Review and Previscan Label ), CORDARONE (View Cordarone Review and Cordarone Label ), APROVEL (View Aprovel Review and Aprovel Label ), LASIX (View Lasix Review and Lasix Label ), GLUCOPHAGE (View Glucophage Review and Glucophage Label ). Patient was hospitalized.

5216880-6 | Mesothelioma Malignant, Pulmonary Oedema
on Jan 05, 2007 Female patient from UNITED STATES , 72 years of age, weighting 178.0 lb, was diagnosed with diarrhoea and was treated with Questran (View Usage). After Questran was administered, patient had the following side effects: mesothelioma malignant, pulmonary oedema. Questran dosage: 1 Df Qd Po. During the same period patient was treated with LISINOPRIL (View Lisinopril Review and Lisinopril Label ).

5191945-6 | Cardio-respiratory Arrest, Pneumonia
Patient was taking Questran (View Usage). Patient experienced the following unwanted or unexpected effects: cardio-respiratory arrest, pneumonia (What is pneumonia?) on Dec 08, 2006 from JAPAN Additional patient health information: Male patient , 80 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?), osteoporosis (What is osteoporosis?), prophylaxis against gastrointestinal ulcer, hypertension and. Questran dosage: . During the same period patient was treated with ARAVA (View Arava Review and Arava Label ), SULFASALAZINE (View Sulfasalazine Review and Sulfasalazine Label ), BENET (View Benet Review and Benet Label ), VOLTAREN XR (View Voltaren-xr Review and Voltaren-xr Label ), CYTOTEC (View Cytotec Review and Cytotec Label ), ROXATIDINE ACETATE HCL (View Roxatidine Acetate Hcl Review and Roxatidine Acetate Hcl Label ), SELECTOL (View Selectol Review and Selectol Label ), ALDOMET (View Aldomet Review and Aldomet Label ). Patient was hospitalized.

5190550-5 | Diarrhoea
Adverse event was reported on Sep 27, 2006 by a Female patient taking Questran (View Usage) (Dosage: ) was diagnosed with diarrhoea and. Location: UNITED STATES , 65 years of age, weighting 200.6 lb, Patient had the following side effects: diarrhoea.

5190548-7 | Abdominal Pain Upper, Diarrhoea
on Mar 31, 2006 Female patient from UNITED STATES , 78 years of age, weighting 112.4 lb, was diagnosed with diarrhoea and was treated with Questran (View Usage). After Questran was administered, patient had the following side effects: abdominal pain upper, diarrhoea. Questran dosage: .

5190547-5 | Ageusia, Anosmia, Gingival Swelling, Lymphadenopathy, Oral Discomfort
on Mar 27, 2006 Female patient from UNITED STATES , 52 years of age, was diagnosed with diarrhoea and was treated with Questran (View Usage). Patient experienced the following unwanted or unexpected effects: ageusia, anosmia, gingival swelling, lymphadenopathy, oral discomfort. Questran dosage: Dosage Form = Scoop.

5171221-8 | Cardio-respiratory Arrest, Obstructive Airways Disorder, Pneumonia
Patient was taking Questran (View Usage). Patient had the following side effects: cardio-respiratory arrest, obstructive airways disorder, pneumonia (What is pneumonia?) on Dec 08, 2006 from JAPAN Additional patient health information: Male patient , 80 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Questran dosage: . During the same period patient was treated with ARAVA (View Arava Review and Arava Label ).

5170267-3 | Dehydration, Diarrhoea, Hypotension, Leukocytosis, Presyncope, Vomiting
Adverse event was reported on Nov 10, 2006 by a Female patient taking Questran (View Usage) (Dosage: ) was diagnosed with fatigue and. Location: FRANCE , 24 years of age, weighting 114.6 lb, After Questran was administered, patient had the following side effects: dehydration, diarrhoea, hypotension, leukocytosis, presyncope, vomiting. Patient was hospitalized.

5150819-7 | Diarrhoea, Presyncope, Vomiting
on Nov 10, 2006 Female patient from FRANCE , 24 years of age, was diagnosed with fatigue and was treated with Questran (View Usage). Patient experienced the following unwanted or unexpected effects: diarrhoea, presyncope, vomiting. Questran dosage: . Patient was hospitalized.

5146752-7 | Cholecystitis, Cholelithiasis, Dysgeusia, Incorrect Dose Administered, Treatment Noncompliance
on Oct 17, 2006 Female patient from UNITED STATES , 42 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Questran (View Usage). Patient had the following side effects: cholecystitis, cholelithiasis, dysgeusia, incorrect dose administered, treatment noncompliance. Questran dosage: Df. During the same period patient was treated with ARAVA (Df) (View Arava Review and Arava Label ). Patient was hospitalized.

5145000-1 | Pulmonary Oedema
Patient was taking Questran (View Usage). After Questran was administered, patient had the following side effects: pulmonary oedema on Oct 27, 2006 from UNITED STATES Additional patient health information: Female patient , 72 years of age, weighting 178.6 lb, was diagnosed with diarrhoea and. Questran dosage: . During the same period patient was treated with LISINOPRIL (View Lisinopril Review and Lisinopril Label ).

5142303-1 | Rhabdomyolysis
Adverse event was reported on Oct 12, 2006 by a Female patient taking Questran (View Usage) (Dosage: 1 Df Bid Po) was diagnosed with hyperlipidaemia and. Location: UNITED STATES , 64 years of age, weighting 298.0 lb, Patient experienced the following unwanted or unexpected effects: rhabdomyolysis. During the same period patient was treated with TRICOR (160 Mg Qday Po) (View Tricor Review and Tricor Label ), METFORMIN (View Metformin Review and Metformin Label ), ACTOS (View Actos Review and Actos Label ), LOTREL (View Lotrel Review and Lotrel Label ), LANTUS (View Lantus Review and Lantus Label ), NEURONTIN (View Neurontin Review and Neurontin Label ), METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ). Patient was hospitalized.

5133469-8 | Rhabdomyolysis
on Oct 19, 2006 Female patient from UNITED STATES , 64 years of age, weighting 297.6 lb, was diagnosed with hyperlipidaemia and was treated with Questran (View Usage). Patient had the following side effects: rhabdomyolysis. Questran dosage: . During the same period patient was treated with TRICOR (View Tricor Review and Tricor Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), ACTOS (View Actos Review and Actos Label ), METOPROLOL (View Metoprolol Review and Metoprolol Label ), LOTREL (View Lotrel Review and Lotrel Label ), LANTUS (View Lantus Review and Lantus Label ), NEURONTIN (View Neurontin Review and Neurontin Label ). Patient was hospitalized.

5081830-2 | Acidosis Hyperchloraemic, Premature Baby
on Apr 12, 2006 Male patient from UNITED KINGDOM , weighting 2.20 lb, was treated with Questran (View Usage). After Questran was administered, patient had the following side effects: acidosis hyperchloraemic, premature baby. Questran dosage: . During the same period patient was treated with VITAMIN K (View Vitamin K Review and Vitamin K Label ), PROPRANOLOL (View Propranolol Review and Propranolol Label ), RIFAMPICIN (View Rifampicin Review and Rifampicin Label ), LABETALOL HCL (View Labetalol Hcl Review and Labetalol Hcl Label ), URSODEOXYCHOLIC ACID (View Ursodeoxycholic Acid Review and Ursodeoxycholic Acid Label ), MULTIVITAMIN (View Multivitamin Review and Multivitamin Label ), PIRITON (View Piriton Review and Piriton Label ), ADCAL (View Adcal Review and Adcal Label ). Patient was hospitalized.

5070762-1 | Acidosis Hyperchloraemic, Hyperchloraemia, Metabolic Acidosis, Pregnancy, Premature Baby
Patient was taking Questran (View Usage). Patient experienced the following unwanted or unexpected effects: acidosis hyperchloraemic, hyperchloraemia, metabolic acidosis, pregnancy (What is pregnancy?), premature baby on Apr 12, 2006 from UNITED KINGDOM Additional patient health information: Male patient , weighting 2.20 lb, . Questran dosage: . During the same period patient was treated with VITAMIN K (View Vitamin K Review and Vitamin K Label ), PROPRANOLOL (View Propranolol Review and Propranolol Label ), RIFAMPICIN (View Rifampicin Review and Rifampicin Label ), LABETALOL HCL (View Labetalol Hcl Review and Labetalol Hcl Label ), URSODEOXYCHOLIC ACID (View Ursodeoxycholic Acid Review and Ursodeoxycholic Acid Label ), MULTIVITAMIN (View Multivitamin Review and Multivitamin Label ), PIRITON (View Piriton Review and Piriton Label ). Patient was hospitalized.

4929224-1 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Creatine Phosphokinase Increased, Prostate Cancer
Adverse event was reported on Mar 11, 2005 by a Male patient taking Questran (View Usage) (Dosage: ) was diagnosed with hypercholesterolaemia, hypertension and. Location: FRANCE , 63 years of age, Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood creatine phosphokinase increased, prostate cancer (What is prostate cancer?). During the same period patient was treated with ALDACTAZINE (View Aldactazine Review and Aldactazine Label ), LOXEN (View Loxen Review and Loxen Label ), ZESTRIL (View Zestril Review and Zestril Label ). Patient was hospitalized.

4853671-X | Hyponatraemia
on Oct 21, 2005 Male patient from UNITED KINGDOM , 70 years of age, weighting 176.4 lb, was diagnosed with diarrhoea, pain (What is pain?), barrett's oesophagus, insomnia, blood cholesterol increased, trigeminal neuralgia (What is trigeminal neuralgia?), osteoarthritis (What is osteoarthritis?) and was treated with Questran (View Usage). After Questran was administered, patient had the following side effects: hyponatraemia. Questran dosage: . During the same period patient was treated with AMITRIPTYLINE HCL (View Amitriptyline Hcl Review and Amitriptyline Hcl Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), NITRAZEPAM (View Nitrazepam Review and Nitrazepam Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), TEGRETOL (View Tegretol Review and Tegretol Label ), ACECLOFENAC (View Aceclofenac Review and Aceclofenac Label ).

4850662-X | Abdominal Pain Upper, Hypertonic Bladder
on Aug 15, 2005 Female patient from UNITED STATES , 58 years of age, weighting 134.5 lb, was diagnosed with cholecystectomy and was treated with Questran (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain upper, hypertonic bladder. Questran dosage: 1 Tablespoon In Six-ounces Of Water.

4850661-8 | Muscular Weakness
Patient was taking Questran (View Usage). Patient had the following side effects: muscular weakness on Jul 26, 2005 from UNITED STATES Additional patient health information: Female patient , weighting 125.7 lb, . Questran dosage: . During the same period patient was treated with LIPITOR (View Lipitor Review and Lipitor Label ).